Journal Information
Vol. 88. Issue S2.
Pages 4 (November - December 2022)
Share
Share
Download PDF
More article options
Vol. 88. Issue S2.
Pages 4 (November - December 2022)
Open Access
Study of the otoprotective effect of dexametasone in ototoxicity induced by cisplatin in rats
Visits
1514
Isabelle Oliveira Jataí Capelo, Marcos Rabelo de Freitas
Corresponding author
marcosrabeloufc@gmail.com

Corresponding author.
Departamento de Otorrinolaringologia, Universidade Federal do Ceará, Fortaleza, CE, Brazil
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 88. Issue S2
More info
Full Text

Objective: To evaluate the protection capacity of dexamethasone against the ototoxicity of cisplatin through the functional evaluations by brainstem evoked response audiometry (BERA) and morphological by optical microscopy.

Methods: Male Wistar rats were divided into four groups: 1. Control: 06 animals received saline intraperitoneal (IP) 8ml/kg/day for four days; 2. CDDP+D15: 11 animals received dexamethasone 15mg/kg/ day via IP and 90minutes (min) after 8mg/kg/day of cisplatin via IP for four days; 3. CDDP+D20: 07 animals received 20mg/kg/day of dexamethasone via IP and 90min after 8mg/kg/day of cisplatin via IP for four days; 4. C+CDDP: 11 animals receive 8ml/kg/day of saline via IP and 90min after 8mg/kg/day of cisplatin via IP for four days.

Results: Based on the results of this study, dexamethasone at the dose of 15mg/kg/day was significantly protected against ototoxicity of cisplatin by means of the functional evaluation by BERA and morphological, through the preservation of vascular stria. There was no protection against systemic toxicity, evaluated through animal weight, with the use of corticosteroids.

Conclusion: Dexamethasone at a dose of 15mg/kg/day protected against ototoxicity by cisplatin in functional evaluation by BERA and morphological by optical microscopy, but did not protect against systemic toxicity.

Keywords: Ototoxicity; Cisplatin; Dexamethasone.

Brazilian Journal of Otorhinolaryngology (English Edition)
Article options
Tools
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.